VNRX VOLITIONRX LTD
Price Chart
Executive Summary
VolitionRx disclosed it violated the minimum market capitalization covenant on its $9.9M in aggregate senior secured convertible notes held by Lind Global Asset Management. Lind waived its rights to accelerate or foreclose on the notes but imposed a 10% penalty on the outstanding principal and secured a more favorable conversion price (90% of the three lowest VWAPs over 20 days). This avoids immediate default but signals severe financial distress and creates heavy future dilution risk.
Actionable Insight
The near-term default risk is deferred, but the 10% penalty and deeply discounted conversion option create a toxic financing structure. Expect heavy selling pressure as Lind converts shares at a discount and flips them. Monitor the next 10-Q for the full waiver text and any further covenant breaches. The stock is likely to trade down on this news.
Key Facts
- VolitionRx failed to maintain the minimum market capitalization covenant on its $7.5M (May 2025) and $2.4M (Jan 2026) senior secured convertible notes held by Lind Global Asset Management.
- Lind waived rights to accelerate, demand payment, or foreclose on collateral due to the covenant breach, but the waiver is conditional and preserves certain conversion rights.
- A 10% penalty on the outstanding principal of each note was triggered by the covenant failure.
- Lind can now convert at the lower of the current conversion price or 90% of the average of the three lowest VWAPs over the 20 trading days before conversion, subject to a 4.99% beneficial ownership cap.
- The waiver was executed on May 21, 2026, just 7 days after a board member (Mickie Henshall) decided not to stand for re-election, suggesting governance instability.
Financial Impact
10% penalty on $9.9M total principal = $990,000 additional liability; conversion at a deep discount to market price will cause significant dilution to existing shareholders.
Risk Factors
- Further market cap decline could trigger additional covenant breaches or force a restructuring.
- Lind's conversion at a 10%+ discount to VWAP will dilute existing shareholders and pressure the stock price.
- The departure of a board member within 7 days of this filing suggests potential governance or strategic disagreements.
- The company may need to raise additional capital on unfavorable terms, further diluting equity.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001477932-26-003416 |
| Document: 0001477932-26-003416-index-headers.html | 0001477932-26-003416 |
| Document: 0001477932-26-003416-index.html | 0001477932-26-003416 |
| Document: 0001477932-26-003416.txt | 0001477932-26-003416 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
today
|
424B5
| $1.38 awaiting T+5 | awaiting T+5 | — | $1.39 (−0.72%) |
|
Jun 5, 2026
4d ago
|
424B5
| $1.79 awaiting T+5 | awaiting T+5 | — | $1.39 (+22.35%) |
|
May 22, 2026
18d ago
|
8-K
| $2.94 $2.32 | ▲ +21.09% | ▲ +22.30% | $1.39 (+52.72%) |
|
May 14, 2026
26d ago
|
8-K
| $2.00 $3.13 | ▲ +56.50% | ▲ +55.54% | $1.39 (−30.50%) |
|
Apr 30, 2026
5w ago
|
10-K/A
| $2.43 $2.25 | ▼ −7.41% | ▼ −9.75% | $1.39 (−42.80%) |
|
Apr 28, 2026
6w ago
|
8-K
| $2.64 $2.49 | ▼ −5.68% | ▼ −8.79% | $1.39 (−47.35%) |
|
Apr 23, 2026
6w ago
|
8-K
| $2.80 $2.64 | ▲ +5.71% | ▲ +7.19% | $1.39 (+50.36%) |
|
Apr 17, 2026
7w ago
|
8-K
| $3.20 $2.72 | ▼ −14.88% | ▼ −15.79% | $1.39 (−56.56%) |
|
Mar 31, 2026
10w ago
|
8-K
| $4.00 $3.45 | ▼ −13.80% | ▼ −17.57% | $1.39 (−65.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access